Nausea and vomiting following thyroid and parathyroid surgery

Sonner, James M.; Hynson, James M.; Clark, Orlo H.; Katz, Jeffrey A.

doi:10.1016/s0952-8180(97)00069-x

Cited by 136 publications

(135 citation statements)

References 26 publications

Supporting

Mentioning

126

Contrasting

Unclassified

Order By: Relevance

“…The use of total intravenous anesthetic with propofol has been shown to offer advantages over inhalation anesthetics in terms of lower rates of postoperative nausea and vomiting. 1 However, there are concerns that propofol interferes with intraoperative PTH measurements. 2,3 Administration of propofol to healthy volunteers resulted in a dose-dependent elevation of serum PTH to the range observed in patients with primary HPT.…”

Section: Résumémentioning

confidence: 99%

Effects of propofol on intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism undergoing parathyroidectomy: a randomized control trial

Kivela

Šprung

Richards

et al. 2011

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Section: Résumémentioning

confidence: 99%

Effects of propofol on intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism undergoing parathyroidectomy: a randomized control trial

Kivela

Šprung

Richards

et al. 2011

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

“…A high incidence of PONV has been reported in female patients undergoing thyroidectomy without antiemetic treatment. Although the reason for the high incidence of PONV after thyroidectomy is not clear, several factors are probably related to including middle-age, the female gender of patients, and vagal stimulation by the surgical handling of the neck [2,12]. In the current study, we reported that 81% of patients in the control group (Group 1) had PONV during the postoperative 24 h. This incidence was higher than that of previous studies of PONV in patients without prophylactic antiemetic treatment who underwent thyroidectomy with inhalation anesthesia (60-65%) [2,[11][12][13].…”

Section: Resultsmentioning

confidence: 99%

Comparison of prophylactic anti-emetic effects of ramosetron between single bolus administration and continuous infusion following bolus administration

Doo

Kim

et al. 2016

Anesth Pain Med

View full text Add to dashboard Cite

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Background:The authors hypothesized that the continuous infusion of ramosetron 0.15 mg following a 0.15 mg bolus administration would maintain higher 5-hydroxytryptamine type 3 receptor occupancy levels and be more effective in preventing postoperative nausea and vomiting (PONV) than a 0.3 mg single bolus administration. We conducted a study to compare the efficacy of single bolus ramosetron administration with the combination of continuous infusion following intravenous bolus administration for PONV prophylaxis. Methods: One hundred and fifty female patients undergoing thyroidectomy were allocated randomly to one of three groups to receive a placebo (Group 1, n = 49), 0.3 mg of IV ramosetron (Group 2, n = 53), or the continuous infusion of 0.15 mg ramosetron following a bolus administration of 0.15 mg of ramosetron (Group 3, n = 48). Anesthesia was maintained with sevoflurane and N2O. The incidence of PONV, nausea severity, and use of rescue antiemetics during the postoperative 24 hours were recorded. Results: Group 1 showed higher incidences of PONV during the postoperative 24 hour than Group 2 (81% vs. 58%, P = 0.02) and Group 3 (81% vs. 48%, P ＜ 0.01), but there was no difference between Groups 2 and 3 (P = 0.39). The use of rescue antiemetics was significantly lower in Groups 2 and 3 than Group 1 during the postoperative 6 to 24 hours. Conclusions: There were no significant differences of incidence and severity of PONV between ramosetron 0.3 mg single bolus administration and the combination of ramosetron infusion after 0.15 mg bolus administration. (Anesth Pain Med 2016; 11: 166-171)

show abstract

“…The need for analgesics is very high in the postoperative period after thyroidectomy operations performed with only general anaesthesia, and it has been reported that this method increases the rate of nausea and vomiting which is already high due to the surgical procedure and affects the patient's comfort and recovery time negatively (5,10). Similarly in our study, the tramadole amount used within the first 24 hours and duration of hospital stay for patients in the control group were found to be significantly higher compared to the patients who received block administration.…”

Section: Discussionmentioning

confidence: 99%

Genel anestezi altında yapılan troid cerrahisinde bilateral yüzeyel servikal blok uygulamasının postoperatif analjezi üzerine etkisi

Çanakçı¹,

Taş²,

Yağan³

et al. 2015

Ege Tıp Dergisi

View full text Add to dashboard Cite

Aim: The purpose of this study was to assess the effect of bilateral superficial cervical plexus block (BSCPB), administered along with general anesthesia in total thyroidectomy surgical operations, on postoperative opioid consumption and the duration of hospital stay. Materials and Methods:A total of 150 patients who underwent total thyroidectomy surgical operations under general anesthesia and had or did not have bilateral superficial cervical plexus blockade (BSCPB), were prospectively evaluated in terms of their postoperative tramadol needs and durations of hospital stay. At the beginning of the surgical intervention after anesthesia induction, 75 patients who received BSCPB administered with a 0.5% of 20 mL levobupivacaine constituted the BSCPB group; on the other hand, 75 patients in the control group received only general anesthesia and no BSCPB was administered. Results: No statistically significant difference was found when age, gender, height, weight and ASA (American Society of Anesthesiologists) physical status classifications of patients in both groups were compared. Only 15 patients out of 75 patients in the BSCPB group (20%) had postoperative opioid needs, whereas this rate was determined as 85% in 64 patients out of 75 patients in the control group (p<0.05). Similarly, the tramadole consumption in the BSCPB group was significantly less when compared to the control group (p<0.05). Postoperative hospital stay in the BSCPB group (2.4±0.6) was also significantly less than that of the control group (4.7±1.6) (p<0.05) Conclusion: Bilateral superficial cervical plexus block administered along with general anesthesia in thyroidectomy operations considerably reduces pain and tramadol need in the postoperative period and lessens the duration of hospital stay.Keywords: Thyroidectomy, superficial cervical plexus block, opioid. Öz Amaç: Total tiroidektomi operasyonların da genel anesteziye ek olarak uygulanan bilateral yüzeyel servikal pleksus bloğu (BYSPB)'nun postoperatif opioid tüketimi ve hastanede yatış süresine etkisini değerlendirmeyi amaçladık. Gereç ve Yöntem: Genel anestezi altında total tiroidektomi operasyonu geçiren, bilateral yüzeyel servikal pleksus blokajı (BYSPB) yapılan ve yapılmayan toplam

show abstract

Nausea and vomiting following thyroid and parathyroid surgery

Cited by 136 publications

References 26 publications

Effects of propofol on intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism undergoing parathyroidectomy: a randomized control trial

Effects of propofol on intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism undergoing parathyroidectomy: a randomized control trial

Comparison of prophylactic anti-emetic effects of ramosetron between single bolus administration and continuous infusion following bolus administration

Genel anestezi altında yapılan troid cerrahisinde bilateral yüzeyel servikal blok uygulamasının postoperatif analjezi üzerine etkisi

Contact Info

Product

Resources

About